SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-21-000303
Filing Date
2021-06-04
Accepted
2021-06-04 16:06:02
Documents
12
Period of Report
2021-06-02
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K clsd-20210602.htm   iXBRL 8-K 42494
  Complete submission text file 0000950170-21-000303.txt   162772

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT clsd-20210602.xsd EX-101.SCH 2441
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT clsd-20210602_lab.xml EX-101.LAB 14046
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT clsd-20210602_pre.xml EX-101.PRE 10380
5 EXTRACTED XBRL INSTANCE DOCUMENT clsd-20210602_htm.xml XML 4900
Mailing Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA GA 30005
Business Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA GA 30005 678-270-3631
Clearside Biomedical, Inc. (Filer) CIK: 0001539029 (see all company filings)

IRS No.: 452437375 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37783 | Film No.: 21996485
SIC: 2834 Pharmaceutical Preparations